2018
DOI: 10.1007/s13668-018-0248-8
|View full text |Cite
|
Sign up to set email alerts
|

Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

Abstract: Purpose of this ReviewThis review assesses the latest evidence linking short-chain fatty acids (SCFA) with host metabolic health and cardiovascular disease (CVD) risk and presents the latest evidence on possible biological mechanisms.Recent FindingsSCFA have a range of effects locally in the gut and at both splanchnic and peripheral tissues which together appear to induce improved metabolic regulation and have direct and indirect effects on markers of CVD risk.SummarySCFA produced primarily from the microbial … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
329
0
7

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 483 publications
(366 citation statements)
references
References 91 publications
6
329
0
7
Order By: Relevance
“…The metabolic activity of A. muciniphila on the host metabolic physiology has also been determined to interact directly with several lipid metabolic substances, including changing the endotoxin level (Ozkul et al, 2017) and short-chain fatty acid (SCFA) production (Ottman et al, 2017b), as well as increasing fatty acid oxidation in the intestine and adipose tissue (Lukovac et al, 2014). As a producer of SCFAs, A. muciniphila has been reported to convert dietary fiber into acetate, propionate, and butyrate; these metabolites can have effects on glucose and lipid homeostasis (Chambers et al, 2018). The SCFA production in the distal ileum induced the action of the various transcription factors to control lipid metabolism and growth; for example, propionate and butyrate stimulation led to an obvious increase in fasting-induced adipocyte factor (Fiaf) production and decreased Gpr43, histone deacetylase (HDAC), and PPARγ expression.…”
Section: Influence Of Akkermansia Muciniphila On Lipid Desregulationmentioning
confidence: 99%
“…The metabolic activity of A. muciniphila on the host metabolic physiology has also been determined to interact directly with several lipid metabolic substances, including changing the endotoxin level (Ozkul et al, 2017) and short-chain fatty acid (SCFA) production (Ottman et al, 2017b), as well as increasing fatty acid oxidation in the intestine and adipose tissue (Lukovac et al, 2014). As a producer of SCFAs, A. muciniphila has been reported to convert dietary fiber into acetate, propionate, and butyrate; these metabolites can have effects on glucose and lipid homeostasis (Chambers et al, 2018). The SCFA production in the distal ileum induced the action of the various transcription factors to control lipid metabolism and growth; for example, propionate and butyrate stimulation led to an obvious increase in fasting-induced adipocyte factor (Fiaf) production and decreased Gpr43, histone deacetylase (HDAC), and PPARγ expression.…”
Section: Influence Of Akkermansia Muciniphila On Lipid Desregulationmentioning
confidence: 99%
“…Recent studies suggest that SCFAs exert multiple beneficial effects on mammalian energy metabolism and may beneficially influence inflammation status in the circulation. [50] The analyses was performed in Metacore. Transcription factor in italics are presented in the list of downregulated probe sets.…”
Section: Fdr [%]mentioning
confidence: 99%
“…Recent studies of gut microbiota have developed extremely fast and their composition and products have been associated with human physical and mental health [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18]. Several sophistic approaches have been established to study gut microbiota, including high-throughput 16S rRNA sequencing, metagenomics, and massive bacterial cloning [19][20][21][22][23][24][25][26][27].…”
Section: Ld-like Structures In Intestinal Bacteriamentioning
confidence: 99%